$4.38
-0.08-1.79%
At close: -
$4.51
0.132.96%
After Hours: Jan 31, 9:03 AM EDT
Aptevo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aptevo Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-17.76 | $-123.95 | 85.7 % |
Q2 | 2024-08-08 | $-61.79 | $-145.04 | 57.4 % |
Q1 | 2024-05-08 | $-368.15 | $-475.08 | 22.5 % |
Q4 | 2024-03-05 | $-65.12 | $-667.48 | 90.2 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2022-08-11 | $0 | $3.42M | -100.0 % |
Q1 | 2022-05-12 | $3.11M | $3.75M | -17.0 % |
Q4 | 2022-03-24 | $3.67M | $3.40M | 7.79 % |
Q3 | 2021-11-12 | $3.10M | $3.65M | -15.2 % |
Aptevo Therapeutics (APVO) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-17.76, which beat the estimate of $-123.95.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.